Recruiting

2

400

RoW

Avitinib Maleate, AC0010, Afatinib, Giotrif, Crizotinib, Xalkori, X-396, ensartinib, Chidamide, Epidaza, Pyrotinib Maleate, SHR1258, AZD3759, Pirotinib, KBP-5209, Nimotuzumab, Pemetrexed, LY231514, Cisplatin, CDDP, Sintilimab, Gemcitabine, LY188011, Carboplatin, NSC 241240

Guangdong Association of Clinical Trials, Chinese Thoracic Oncology Group

Carcinoma, Non-Small-Cell Lung

12/22

12/24